Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.
about
Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementMini-review: emerging roles of microRNAs in the pathophysiology of renal diseasesSulforaphane Protects against Cardiovascular Disease via Nrf2 ActivationRegulation of cellular communication by signaling microdomains in the blood vessel wall.Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agentsHyperglycemia-induced diaphragm weakness is mediated by oxidative stress.Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease.Targeting metabolic disorders by natural products.MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.Reactive oxygen species and the cardiovascular systemReactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical researchNox4 and diabetic nephropathy: with a friend like this, who needs enemies?Diabetic nephropathy--emerging epigenetic mechanisms.The regulatory roles of NADPH oxidase, intra- and extra-cellular HSP70 in pancreatic islet function, dysfunction and diabetes.Are reactive oxygen species still the basis for diabetic complications?Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy.High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARα and PPARβ/δ.NADPH oxidase-generated reactive oxygen species are required for stromal cell-derived factor-1α-stimulated angiogenesis.Diabetic complications: current challenges and opportunities.NADPH oxidase 4 mediates ROS production in radiation-induced senescent cells and promotes migration of inflammatory cells.Oxidative stress and reactive oxygen species: a review of their role in ocular disease.Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways.Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy.Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.Radiation-induced inflammation and autoimmune diseases.Melatonin nephroprotective action in Zucker diabetic fatty rats involves its inhibitory effect on NADPH oxidase.Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications
P2860
Q26861119-3AB71086-401A-4B5F-A506-DCC5C79397E7Q28354033-22E6E3A2-F7F1-41C6-A835-DA848EFA18E0Q28393421-EC9596D8-7650-4107-A752-FD46BA69E289Q30406156-EC0EBFAE-E0A3-4F40-A19A-0F33493F8664Q33660629-2B342151-FD02-4607-A5AF-CFDD5477E1CAQ33705075-90A5D77A-FFC2-40FF-A318-1C9AD7AEB6C8Q33751226-1387A605-9846-4825-BD38-9B55315A3E22Q34350546-2083D7A9-E198-4847-BF50-B87E9450CE0EQ35450699-837CDDA5-2959-4F34-9E76-61FAE5E16AD3Q35830892-5B151E17-31AB-4CF1-956C-D8DDF46137C1Q36166755-A57729EC-19DC-4394-8329-FFF6FD3384CEQ36848849-4C3225E9-36DC-4788-9B32-7F2748F5BAB6Q37433974-9A0DA95C-FFA4-406C-BE88-43874AD02CFAQ38092960-C7C3B724-656E-41C1-80D3-0EC4188393B6Q38227252-7CE1B520-34D5-4360-A189-49E8F77E19D0Q38424338-DC860ADA-D1B4-4DA9-A0D1-FE0BD520D870Q38451253-20D6BDFD-8564-4606-8BEC-1196D3705C3DQ38463463-7FFFCBF6-23A0-481E-AFA8-474B5A75A587Q38649653-56634F01-7A35-4E7B-B588-223C1C9FCE3AQ38873909-FB2674A2-F1D7-437A-8C89-F2A7B19FC30AQ38905577-4A4B50EC-0EFC-4FC4-8847-690B310D19A1Q41786123-3CFD1BFC-0217-40FC-918B-EACDFF4B997FQ43109414-3C5761EE-147E-4FD1-B986-335F34C6D272Q46243640-136FE44E-355A-4FA0-BB4E-2E16F0A267C5Q46248374-4975BA89-A7D6-42DE-8A5A-EB736D69F10CQ46819734-41D7F1E1-D3B6-4F5F-8B0F-4BB66D0C6466Q49833824-FE2CD19B-1FAF-49FC-8EB2-1863BC9D27C8Q50874501-03F2D31B-0904-42B0-819E-A640F424A8D2Q51274280-239750CC-CD96-41DE-B72E-962F97C87051Q53176987-947E84E3-4F49-488C-9A5C-2C57AE0AACF4Q53295837-5F3BBB86-5F30-43C1-9B27-04BC6E610F0CQ58558363-D76E7C9E-82D6-436B-9518-F4A985AD8700
P2860
Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Oxidative stress, Nox isoforms ...... l targets for novel therapies.
@en
type
label
Oxidative stress, Nox isoforms ...... l targets for novel therapies.
@en
prefLabel
Oxidative stress, Nox isoforms ...... l targets for novel therapies.
@en
P2093
P2860
P50
P1476
Oxidative stress, Nox isoforms ...... l targets for novel therapies.
@en
P2093
Elyse Di Marco
Ernesto L Schiffrin
Karin Jandeleit-Dahm
Mark E Cooper
Mona Sedeek
Richard L Hebert
Stephen P Gray
P2860
P2888
P304
P356
10.1007/S12265-012-9387-2
P407
P577
2012-06-19T00:00:00Z
P5875
P6179
1030575235